Novavax was just given the green light by the U.S. Food and Drug Administration (FDA) to start mass producing yet another new "vaccine" for the Wuhan coronavirus (COVID-19). This latest jab is protein-based and targets the so-called JN.1 variant of the Chinese virus. Like the many others before it, Novavax's JN.1 injection was granted emergency use authorization (EUA) … Continue reading FDA authorizes yet another COVID “vaccine” – and once again WITHOUT clinical data to back it
Dr. Eddy Bettermann MD 